Can IRB consent forms be signed electronically?

Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. §7001) and UETA in adopted states. Ensure the chosen method captures signer intent, attribution, and retention to meet the four-prong legal test.

Do I need a notarized consent form?

Not typically. Most IRBs do not require notarization for consent. If notarization or witness signatures are required by state law or specific procedures, the IRB will specify that need in its guidance.

How long must I retain IRB records?

Follow institutional policy and federal standards: retain study records during the study and for several years after completion. For health records, follow HIPAA retention (6 years under 45 CFR §164.530(j)).

What happens if documents contain conflicting dates or versions?

IRBs will typically place the submission on hold and request corrected files. Maintain clear version control and label attachments with version dates to avoid delays.

Are remote notarizations acceptable for research documents?

Remote online notarization is permitted in many states but varies by jurisdiction. Verify state notary rules before relying on RON for consent or authorization forms.

How should PHI be handled in electronic submissions?

Limit PHI in submissions where possible, use de-identified datasets for review, and ensure the platform meets HIPAA requirements with a signed BAA when PHI is transmitted or stored electronically.

Electronic Signature
Templates
Healthcare
Healthcare IRB Document

Healthcare IRB Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

INSTITUTIONAL REVIEW BOARD (IRB) PROTOCOL SUBMISSION

Study Title:

Principal Investigator and Contact Information

Principal Investigator - Full Legal Name Department / Institution

Office Phone:

Email:

Mailing Address

Study Personnel

Co-Investigators and Key Study Staff (names, roles, credentials)

Funding and Conflicts of Interest

Primary Funding Source:

Describe any financial interests or conflicts of interest for investigators

Study Overview and Objectives

Brief Protocol Summary (purpose, hypothesis, primary endpoints)

Study Population and Recruitment

Target Enrollment (number of subjects):

Age Range: From to years

Inclusion Criteria Exclusion Criteria Recruitment Methods (check all that apply)

Research registries Clinic patients Public advertisement Direct clinician referral

Detailed Recruitment Procedures

Study Procedures and Timeline

Procedures Performed (describe sequence, duration, frequency)

Anticipated Study Start Date: Anticipated Completion Date:

Risks, Benefits, and Monitoring

Potential Risks and Discomforts Potential Benefits (to subjects and to society) Monitoring and Safety Oversight

Consent Process and HIPAA Authorization

Consent Type: Written Verbal Electronic

Who Will Obtain Consent

Will consent be obtained from legally authorized representative or guardian for any subjects? Yes No

HIPAA Authorization

Does the study require access to or use of Protected Health Information (PHI)? Yes No

If PHI is used, describe specific identifiers requested and justification

HIPAA Authorization Expiration Date (if applicable):

Data Management, Confidentiality, and Record Retention

Data Collection and Storage Procedures Data Retention Period and Disposal Plan

Vulnerable Populations and Special Considerations

Will the study involve any of the following vulnerable populations? (check all that apply)

Children Prisoners Pregnant women Cognitively impaired adults

If yes, describe safeguards and additional protections

Materials and Attachments Checklist

Include the following documents with this submission (check all that are attached):

Complete protocol Consent form(s) Recruitment materials Data collection instruments

HIPAA authorization (if required) Funding contracts/grant documents

Requested Review Type

Exempt review Expedited review Full board review

Principal Investigator Certification

By signing below, I certify that the information provided in this submission is complete and accurate to the best of my knowledge. I acknowledge that:

All research involving human subjects will be conducted in accordance with applicable federal regulations, institutional policies, and the determinations of the IRB.
No human subject research activities will commence prior to IRB approval and any required authorizations.
I will promptly report unanticipated problems, serious adverse events, and proposed protocol changes to the IRB as required.
I will maintain complete and accurate records of recruitment, consent, data collection, and regulatory documents for the retention period required by institution policy and applicable regulations.

Additional certifications or comments

Principal Investigator (Printed Name):

Signature:

Date:

What the Healthcare IRB Document Is and when it applies

A Healthcare IRB Document is the set of materials submitted to an Institutional Review Board to request review and oversight of research involving human subjects. Typical submissions include the study protocol, informed consent form, recruitment materials, investigator brochure, data management plan, and any attachments such as questionnaires or HIPAA authorizations. The IRB evaluates risks and benefits, subject protections, consent language, and data privacy controls before issuing approval, conditional approval, or a request for revisions. Electronic submission and retention are generally accepted when the record meets ESIGN and applicable state rules.

Why a well-prepared Healthcare IRB Document matters

A complete, accurate IRB submission reduces review cycles, clarifies consent, and demonstrates regulatory compliance. Proper documentation supports human subject protections, helps secure funding, and limits administrative delays under 45 CFR 46 and FDA oversight where applicable.

Who typically prepares and reviews Healthcare IRB Documents

Institutional teams and researchers coordinate IRB submissions; each role has specific responsibilities during preparation and review.

Principal investigators and co-investigators preparing the protocol and consent materials for submission.
IRB coordinators and administrators who manage intake, correspondence, and board scheduling.
Clinical research coordinators and data managers who supply data protection and recruitment details.

Clear role separation helps ensure timely review and reduces the chance of noncompliance or protocol amendments after approval.

Essential components to include in a professional IRB submission

A complete Healthcare IRB Document bundle should present the study clearly, address participant protections, and provide evidence of training and safeguards for PHI and study data.

Study Protocol

Describe objectives, design, inclusion/exclusion criteria, sample size rationale, study timeline, interventions, and procedures so reviewers can assess risk versus benefit.

Informed Consent

Provide plain-language consent text, risk/benefit disclosures, alternatives, confidentiality provisions, contact information, and signature blocks for subjects or legally authorized representatives.

Data Management

Explain data collection, storage, de-identification, encryption, access controls, and plans for sharing or destruction of identifiable data.

Recruitment Materials

Include all scripts, advertisements, flyers, and electronic outreach showing how subjects are identified and contacted to ensure non-coercive language.

Safety Monitoring

Provide adverse event reporting plans, DSMB details if applicable, stopping rules, and contact info for timely safety notifications.

Regulatory Attachments

Attach investigator CVs, HIPAA authorizations, training certificates (e.g., human subjects protection), and any sponsor agreements or clinical trial registration info.

Required information and key data points

Study Title: Official protocol name

Principal Investigator: Full legal name

Sponsor: Funding organization

IRB ID: Institutional tracking number

Effective Dates: Start and end dates

Consent Versions: Version date and page count

Step-by-step: completing and submitting an IRB package

Follow these steps to assemble and submit a complete package and reduce the chance of administrative hold.

01

Gather documents: Collect protocol, consent, CVs, and recruitment materials.
02

Complete fields: Populate online form fields with exact names and dates.
03

Upload attachments: Attach labeled PDFs and confirm versions.
04

Submit and monitor: Submit via portal and watch for IRB queries.

How to set up an electronic IRB submission workflow

Configure the online workflow to collect signatures, route approvals, and preserve an audit trail for regulatory review.

Field	Configuration
Signers & routing	Specify PI, co-investigators, and required administrative reviewers
Authentication	Use institutional SSO or two-factor for identity verification
Conditional fields	Reveal HIPAA or minors sections when applicable
Audit settings	Capture timestamps, IP, and signer attribution

Where to file and who receives the Healthcare IRB Document

IRB submissions typically go through an institutional IRB portal; external sponsors may require parallel submission or registration with a sponsor portal.

Institutional IRB Portal: Primary submission channel for local review
ClinicalTrials.gov: Register when trial requires public listing
Sponsor Portal: Submit copies if sponsor requires oversight
Regulatory Agencies: Notify FDA or OHRP when applicable

How to share, sign, and store IRB documents electronically

Use a platform that preserves an audit trail, supports PDF and DOCX, and meets HIPAA and institutional IT security requirements.

File formats: PDF/A or DOCX preferred
Integrations: Support for Google Workspace and Box
Authentication: SSO and multifactor options

Ensure the chosen workflow supports export of a signed package and secure archival consistent with institutional records retention policies.

Typical IRB timelines and review deadlines to expect

Timelines vary by IRB type (expedited, full board, exempt) and institutional workload; plan submissions to accommodate review cycles and sponsor milestones.

Initial IRB review:

Typically 2–8 weeks depending on board schedule and completeness

Expedited reviews:

Often completed in 1–2 weeks for minimal-risk studies

Continuing review:

Annual or at intervals specified by the IRB

Amendment processing:

Allow 1–4 weeks for minor amendments; longer for substantive changes

Adverse event reporting:

Report immediately per IRB and FDA requirements

Key milestones from submission to study activation

Use a milestone timeline to coordinate sponsor requirements, site initiation, and participant recruitment.

01

Protocol submission

Submit full package and receive confirmation of receipt

02

IRB review decision

Receive approval, conditional approval, or request for changes

03

Document revisions

Address queries and submit revised materials

04

Activation and enrollment

Begin recruitment once final approval and site activation are complete

Common errors that delay IRB processing

Incomplete consent language or missing signature blocks causing IRB to request revisions.
Mismatched names or dates across forms and attachments leading to administrative holds.
Missing documentation of training or CVs for key study personnel, triggering compliance queries.
Incorrectly labeled versions of consent or protocol files creating version-control confusion.

Consequences of an incorrect or noncompliant IRB submission

Regulatory Sanctions: OHRP or FDA findings possible

Funding Impact: Sponsor holds or funding delays

Study Suspension: Temporary or permanent suspension

Legal Exposure: Civil liability or corrective action

Data Exclusion: Noncompliant data may be unusable

Reputational Risk: Institutional and investigator reputational harm

Who signs and certifies an IRB submission

Principal Investigator

The PI signs to certify the accuracy of the submission, confirm training, and accept responsibility for protocol conduct. The PI must ensure all delegated personnel are qualified and that consent is obtained correctly.

IRB Chair or Designee

An authorized IRB official signs approval letters and conditions; their signature documents institutional oversight and is required for study activation and sponsor compliance.

Practical examples of IRB submissions and outcomes

Two concise examples show how clear documentation changes review outcomes and operational timelines.

Minimal-Risk Survey Study

Intro: A university team submitted a blank survey protocol with clear consent text and a data de-identification plan.

Point: IRB classified it as expedited review.
Outro: The university received approval in two weeks without requested edits and began recruitment with sponsor clearance and institutional data use agreements in place.

Interventional Clinical Trial

Intro: A clinical investigation included a detailed adverse event plan and DSMB charter at initial submission.

Point: The IRB requested only minor wording changes.
Outro: Final approval arrived in six weeks; clear safety monitoring language reduced amendment cycles and streamlined site initiation visits.

eSignature solution pricing and feature comparison relevant to IRB workflows

Compare commonly evaluated criteria for eSignature tools used to collect consents and IRB approvals; signNow is listed first per standard vendor comparison practice.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently asked questions about Healthcare IRB Documents

Answers address common points of confusion when preparing, submitting, and storing IRB materials electronically.

Need help? Contact support

Can IRB consent forms be signed electronically?
Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. §7001) and UETA in adopted states. Ensure the chosen method captures signer intent, attribution, and retention to meet the four-prong legal test.
Do I need a notarized consent form?
Not typically. Most IRBs do not require notarization for consent. If notarization or witness signatures are required by state law or specific procedures, the IRB will specify that need in its guidance.
How long must I retain IRB records?
Follow institutional policy and federal standards: retain study records during the study and for several years after completion. For health records, follow HIPAA retention (6 years under 45 CFR §164.530(j)).
What happens if documents contain conflicting dates or versions?
IRBs will typically place the submission on hold and request corrected files. Maintain clear version control and label attachments with version dates to avoid delays.
Are remote notarizations acceptable for research documents?
Remote online notarization is permitted in many states but varies by jurisdiction. Verify state notary rules before relying on RON for consent or authorization forms.
How should PHI be handled in electronic submissions?
Limit PHI in submissions where possible, use de-identified datasets for review, and ensure the platform meets HIPAA requirements with a signed BAA when PHI is transmitted or stored electronically.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now